{"id":"recombinant-follicle-stimulating-hormone","safety":{"commonSideEffects":[{"rate":null,"effect":"Ovarian hyperstimulation syndrome (OHSS)"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Abdominal pain/bloating"},{"rate":null,"effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL415111","moleculeType":"Protein","molecularWeight":"1622.88"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"FSH is a gonadotropin that acts on FSH receptors (FSHR) expressed on ovarian granulosa cells, promoting their proliferation and differentiation. This leads to follicular development, increased estrogen secretion, and preparation of oocytes for ovulation. The recombinant form is produced using genetic engineering to provide a consistent, pure source of the hormone for therapeutic use.","oneSentence":"Recombinant FSH binds to follicle-stimulating hormone receptors on granulosa cells to stimulate follicular growth and estrogen production in the ovaries.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:04:02.719Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Infertility in women undergoing assisted reproductive technology (ART)"},{"name":"Anovulation and ovulatory disorders in women"}]},"trialDetails":[{"nctId":"NCT06378268","phase":"NA","title":"PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-04-24","conditions":"Progestins Primed Ovarian Stimulation","enrollment":626},{"nctId":"NCT07269327","phase":"PHASE1","title":"An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2025-11-24","conditions":"Fertility","enrollment":24},{"nctId":"NCT02871167","phase":"NA","title":"Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2016-12","conditions":"Breast Cancer","enrollment":140},{"nctId":"NCT07340827","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)","status":"RECRUITING","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2026-02-05","conditions":"Infertility","enrollment":333},{"nctId":"NCT07466199","phase":"PHASE4","title":"Exogenous Progesterone as Ovulation Trigger","status":"NOT_YET_RECRUITING","sponsor":"Instituto Valenciano de Infertilidade de Lisboa","startDate":"2026-04","conditions":"Ovulation, Ovarian Function, Assisted Reproductive Treatments","enrollment":10},{"nctId":"NCT07457684","phase":"","title":"Comparison of Follitropin Delta and Follitropin Alfa in Combination With Menotropin","status":"COMPLETED","sponsor":"Clinique Ovo","startDate":"2025-12-05","conditions":"IVF Outcomes, OVARIAN STIMULATION","enrollment":846},{"nctId":"NCT06134479","phase":"PHASE3","title":"Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2023-12-12","conditions":"Fertility","enrollment":194},{"nctId":"NCT07097259","phase":"PHASE1","title":"A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants","status":"COMPLETED","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2025-07-21","conditions":"Hypogonadism","enrollment":55},{"nctId":"NCT06864793","phase":"PHASE1","title":"Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2025-04-06","conditions":"Infertility, Female","enrollment":48},{"nctId":"NCT06173869","phase":"PHASE3","title":"A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2024-03-29","conditions":"Infertility, Female","enrollment":301},{"nctId":"NCT07348757","phase":"","title":"rFSH vs rFSH+rLH in Dydrogesterone-Based Progestin Protocol: A Prospective Study","status":"RECRUITING","sponsor":"Centrum Clinic IVF Center","startDate":"2026-01-05","conditions":"InVitro Fertilization, Gonadotropins","enrollment":300},{"nctId":"NCT06440850","phase":"PHASE2","title":"Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-07-15","conditions":"Thyroid Gland Follicular Carcinoma, Thyroid Gland Oncocytic Carcinoma, Thyroid Gland Papillary Carcinoma","enrollment":21},{"nctId":"NCT07346235","phase":"PHASE3","title":"150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial","status":"NOT_YET_RECRUITING","sponsor":"American Hospital 2 Kosovo","startDate":"2026-03-01","conditions":"Infertility, Female","enrollment":440},{"nctId":"NCT06175832","phase":"PHASE4","title":"PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2025-01-27","conditions":"Ovarian Stimulation, Quality of Life, Preimplantation Genetic Testing","enrollment":60},{"nctId":"NCT04166825","phase":"NA","title":"Ovarian Hyperstimulation and Fibrin Clot Properties.","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2019-11-18","conditions":"Fibrin Blood Clot, Infertility, Female, Endometriosis","enrollment":300},{"nctId":"NCT02892942","phase":"PHASE4","title":"NATural Ovarian Stimulation","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-01-13","conditions":"Infertility","enrollment":129},{"nctId":"NCT06877429","phase":"","title":"Is the Diurnal Variation in Circulating Levels of Cortisol Reflected in Follicular Fluid of Preovulatory Follicles Close to Ovulation?","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":"Healthy","enrollment":20},{"nctId":"NCT06879002","phase":"","title":"Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":"Stimulation in the Ovary, IVF Outcome","enrollment":252},{"nctId":"NCT06193135","phase":"NA","title":"Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA)","status":"RECRUITING","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2025-07-08","conditions":"Infertility, Female, Reproductive Sterility","enrollment":318},{"nctId":"NCT07128394","phase":"NA","title":"Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment","status":"RECRUITING","sponsor":"Nanjing University","startDate":"2024-02-01","conditions":"Infertility, Female, Luteinizing Hormone (LH)","enrollment":590},{"nctId":"NCT07121751","phase":"PHASE4","title":"Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)","status":"NOT_YET_RECRUITING","sponsor":"Dunamenti REK Istenhegyi IVF Center","startDate":"2025-09-01","conditions":"Hypo-responder, Infertility (IVF Patients), OVARIAN STIMULATION","enrollment":150},{"nctId":"NCT06732843","phase":"","title":"Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-07-23","conditions":"OVARIAN STIMULATION, Telomere Length, Telomere Length, Mean Leukocyte","enrollment":10},{"nctId":"NCT07076719","phase":"","title":"Cell-free DNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for Preimplantation Genetic Diagnosis","status":"COMPLETED","sponsor":"Sohag University","startDate":"2023-10-01","conditions":"to Evaluate the Feasibility and Accuracy of Using cfDNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for PGD","enrollment":20},{"nctId":"NCT05815719","phase":"PHASE4","title":"Continuous Double Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2022-11-17","conditions":"Fertility Issues","enrollment":30},{"nctId":"NCT06966219","phase":"","title":"Trigger Protocol on the Rate of Pregnancy After Intracytoplasmic Sperm Injection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suez University","startDate":"2025-05-01","conditions":"Infertility","enrollment":90},{"nctId":"NCT06921395","phase":"PHASE4","title":"Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).","status":"RECRUITING","sponsor":"LG Chem","startDate":"2025-02-15","conditions":"Female Infertility","enrollment":248},{"nctId":"NCT06321107","phase":"","title":"Long-term Follow-up Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference","status":"ACTIVE_NOT_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2024-03-01","conditions":"Infertility","enrollment":158},{"nctId":"NCT05263388","phase":"PHASE3","title":"A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2022-07-15","conditions":"Infertility","enrollment":302},{"nctId":"NCT05173597","phase":"","title":"Real-world Evidence on Follitropin Delta Individual Dosing","status":"RECRUITING","sponsor":"University of Luebeck","startDate":"2021-12-08","conditions":"Infertility, Sterility","enrollment":850},{"nctId":"NCT03737253","phase":"NA","title":"Hormone Evaluation in Artificial Reproductive Technology","status":"COMPLETED","sponsor":"Lund University","startDate":"2016-09","conditions":"Female Infertility","enrollment":810},{"nctId":"NCT06280560","phase":"","title":"Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation","status":"RECRUITING","sponsor":"Fundación IVI","startDate":"2024-02-01","conditions":"Endometrial Receptivity","enrollment":60},{"nctId":"NCT06572930","phase":"","title":"Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2024-12-16","conditions":"Ovarian Stimulation","enrollment":150},{"nctId":"NCT04773353","phase":"PHASE3","title":"Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian Women","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2021-12-03","conditions":"Infertility","enrollment":220},{"nctId":"NCT06778733","phase":"EARLY_PHASE1","title":"Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders","status":"COMPLETED","sponsor":"University of Athens","startDate":"2022-01-01","conditions":"Female Infertility","enrollment":22},{"nctId":"NCT06778304","phase":"PHASE1","title":"Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30","status":"COMPLETED","sponsor":"West China Second University Hospital","startDate":"2021-01-04","conditions":"Bioequivalence, Healthy Volunteers, Pharmacokinetics","enrollment":48},{"nctId":"NCT05330130","phase":"PHASE1","title":"Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells","status":"COMPLETED","sponsor":"ART Fertility Clinics LLC","startDate":"2023-07-05","conditions":"Ovarian Function Insufficiency, Fertility Issues, Infertility,Female","enrollment":6},{"nctId":"NCT04997525","phase":"PHASE4","title":"Estradiol and Progesterone Levels Following Frozen Embryo Transfer","status":"COMPLETED","sponsor":"Copenhagen University Hospital at Herlev","startDate":"2021-04-20","conditions":"Infertility","enrollment":305},{"nctId":"NCT05103228","phase":"NA","title":"Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders","status":"COMPLETED","sponsor":"Peter Kovacs MD","startDate":"2021-12-02","conditions":"Infertility, Ovarian Dysfunction","enrollment":190},{"nctId":"NCT06091436","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-03-24","conditions":"Infertility","enrollment":176},{"nctId":"NCT06095206","phase":"PHASE1","title":"The Pharmacokinetic and Bioavailability of GenSci094 Before and After a Change in Manufacturing Site","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-09-19","conditions":"Infertility","enrollment":48},{"nctId":"NCT06414096","phase":"PHASE1","title":"Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2024-10-01","conditions":"Infertility, Obesity","enrollment":5},{"nctId":"NCT00703014","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-07-13","conditions":"Pregnancy, Neonates","enrollment":541},{"nctId":"NCT00702338","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-05-15","conditions":"Pregnancy, Neonates","enrollment":1},{"nctId":"NCT00702520","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-01","conditions":"Pregnancy, Neonates","enrollment":15},{"nctId":"NCT00702273","phase":"","title":"Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-19","conditions":"In Vitro Fertilization","enrollment":344},{"nctId":"NCT00702234","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-02-15","conditions":"Pregnancy, Neonates","enrollment":268},{"nctId":"NCT06571214","phase":"PHASE4","title":"Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment","status":"NOT_YET_RECRUITING","sponsor":"Nanjing University","startDate":"2024-09-01","conditions":"Infertility","enrollment":300},{"nctId":"NCT06561594","phase":"PHASE3","title":"To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection","status":"NOT_YET_RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2024-09-20","conditions":"Idiopathic Hypogonadotropic Hypogonadism","enrollment":60},{"nctId":"NCT00598208","phase":"PHASE2","title":"A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-05-19","conditions":"Fertilization","enrollment":325},{"nctId":"NCT00702806","phase":"PHASE2","title":"Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-07-01","conditions":"Infertility, In Vitro Fertilization","enrollment":99},{"nctId":"NCT00702195","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Phase II Clinical Trials of Org 36286 (Study 38817)(P06054)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-01-01","conditions":"Pregnancy","enrollment":29},{"nctId":"NCT01921166","phase":"PHASE4","title":"Maximal Stimulation and Delayed Fertilization for Diminished Ovarian Reserve: a Randomized Pilot Study","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2011-01","conditions":"Infertility","enrollment":23},{"nctId":"NCT06481696","phase":"NA","title":"Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility","status":"RECRUITING","sponsor":"Andros Day Surgery Clinic","startDate":"2024-06-01","conditions":"Unexplained Infertility","enrollment":90},{"nctId":"NCT00696800","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06-27","conditions":"In Vitro Fertilization","enrollment":1509},{"nctId":"NCT01146418","phase":"PHASE3","title":"Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-06-02","conditions":"Infertility","enrollment":307},{"nctId":"NCT00702845","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12-28","conditions":"Infertility","enrollment":397},{"nctId":"NCT00696878","phase":"PHASE3","title":"Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-09-26","conditions":"In Vitro Fertilization","enrollment":682},{"nctId":"NCT00697255","phase":"PHASE2","title":"A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2007-05-15","conditions":"Ovulation Induction","enrollment":8},{"nctId":"NCT01421095","phase":"NA","title":"Ovarian Reserve Testing in Female Young Adult Cancer Survivors","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Diego","startDate":"2011-01-01","conditions":"Cancer, Infertility","enrollment":34},{"nctId":"NCT02478775","phase":"NA","title":"Dysregulation of FSH in Obesity: Functional and Statistical Analysis","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2015-07","conditions":"Obesity, Fertility","enrollment":99},{"nctId":"NCT04719000","phase":"PHASE4","title":"PErsonalized Addition of Recombinant LH in Ovarian Stimulation","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-02-04","conditions":"Infertility","enrollment":120},{"nctId":"NCT04695483","phase":"PHASE4","title":"Reduction of Progesterone Elevation at Trigger in POR After Long Acting COS Compared With Daily COS: a Prospective Randomized Trial","status":"COMPLETED","sponsor":"IRCCS San Raffaele","startDate":"2022-02-22","conditions":"Infertility","enrollment":110},{"nctId":"NCT04487925","phase":"PHASE4","title":"Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2022-01-25","conditions":"Ovarian Reserve, Poor Responders, IVF","enrollment":208},{"nctId":"NCT04989348","phase":"NA","title":"Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol","status":"COMPLETED","sponsor":"Shanghai First Maternity and Infant Hospital","startDate":"2021-08-04","conditions":"IVF","enrollment":240},{"nctId":"NCT05405686","phase":"PHASE4","title":"Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders","status":"WITHDRAWN","sponsor":"CRG UZ Brussel","startDate":"2023-05-01","conditions":"Poor Response to Ovulation Induction","enrollment":""},{"nctId":"NCT05670795","phase":"NA","title":"Comparison of Recombinant Follicle Stimulating Hormone and the Combination of Recombinant Follicle Stimulating Hormone With Clomiphene Citrate in Stimulated Intrauterine Insemination Cycles","status":"UNKNOWN","sponsor":"Bezmialem Vakif University","startDate":"2023-01-01","conditions":"Infertility Unexplained","enrollment":254},{"nctId":"NCT06227949","phase":"PHASE3","title":"FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients","status":"NOT_YET_RECRUITING","sponsor":"Ellen Greenblatt","startDate":"2024-02","conditions":"Fertility Preservation","enrollment":140},{"nctId":"NCT03738618","phase":"PHASE3","title":"Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2018-10-29","conditions":"Infertility, Female","enrollment":588},{"nctId":"NCT03740737","phase":"PHASE3","title":"Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2018-10-26","conditions":"Infertility","enrollment":579},{"nctId":"NCT06199960","phase":"PHASE3","title":"Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian Responders","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2019-08-02","conditions":"Assisted Reproductive Techniques","enrollment":116},{"nctId":"NCT00415233","phase":"PHASE3","title":"High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer","status":"UNKNOWN","sponsor":"University College, London","startDate":"2006-11","conditions":"Head and Neck Cancer","enrollment":438},{"nctId":"NCT05567731","phase":"NA","title":"Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-10-15","conditions":"Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility","enrollment":30},{"nctId":"NCT04724486","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04724343","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04727684","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Infertility, Intracytoplasmic Sperm Injection","enrollment":50},{"nctId":"NCT04727671","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04447872","phase":"NA","title":"The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol","status":"UNKNOWN","sponsor":"Northwell Health","startDate":"2020-09-15","conditions":"Infertility, Diminished Ovarian Reserve, IVF","enrollment":142},{"nctId":"NCT02554279","phase":"PHASE4","title":"MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2015-08-31","conditions":"Infertility","enrollment":620},{"nctId":"NCT06048666","phase":"PHASE3","title":"Platelet Rich Plasma on Ovarian Reserve Parameters and Intra Cytoplasmic Sperm Injection Outcomes in Patients With Diminished Ovarian Reserve","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-10-30","conditions":"IVF","enrollment":56},{"nctId":"NCT01956123","phase":"PHASE3","title":"Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2014-03-26","conditions":"Infertility","enrollment":513},{"nctId":"NCT03564509","phase":"PHASE2","title":"A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2018-05-14","conditions":"Controlled Ovarian Stimulation","enrollment":620},{"nctId":"NCT03296527","phase":"PHASE3","title":"Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian Women","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2017-12-01","conditions":"Controlled Ovarian Simulation","enrollment":1011},{"nctId":"NCT03228680","phase":"PHASE3","title":"Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2017-07-29","conditions":"Infertility","enrollment":373},{"nctId":"NCT05266924","phase":"PHASE3","title":"Recombinant Follicle-stimulating Hormone in Treatment for Infertility","status":"UNKNOWN","sponsor":"Bharat Serums and Vaccines Limited","startDate":"2022-07-23","conditions":"Female Infertility","enrollment":250},{"nctId":"NCT04992468","phase":"PHASE4","title":"Dual Trigger for Elective Fertility Preservation","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-10-05","conditions":"Infertility","enrollment":136},{"nctId":"NCT01267604","phase":"PHASE4","title":"Ovarian Stimulation: Inositol and Melatonin","status":"WITHDRAWN","sponsor":"AGUNCO Obstetrics and Gynecology Centre","startDate":"2010-12","conditions":"Infertility","enrollment":""},{"nctId":"NCT03755973","phase":"PHASE4","title":"Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity","status":"COMPLETED","sponsor":"Instituto Valenciano de Infertilidade de Lisboa","startDate":"2020-01-29","conditions":"Infertility, Female, Endometrial Diseases","enrollment":24},{"nctId":"NCT04931355","phase":"NA","title":"Acupuncture in the Freeze-all IVF Cycle","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2023-06-01","conditions":"Acupuncture, Female Infertility","enrollment":90},{"nctId":"NCT04586686","phase":"NA","title":"Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-11-01","conditions":"Breast Cancer Female","enrollment":41},{"nctId":"NCT04616729","phase":"PHASE1, PHASE2","title":"DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-11-01","conditions":"Breast Cancer Female","enrollment":30},{"nctId":"NCT05864937","phase":"","title":"C677T Methylenetetrahydrofolate Reductase Mutation","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2011-12-01","conditions":"Mutation","enrollment":363},{"nctId":"NCT03767218","phase":"PHASE3","title":"Initiation of Ovarian Stimulation With Recombinant-human FSH (Bemfola®) in the Late Follicular Phase","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2018-11-01","conditions":"Infertility, Female","enrollment":71},{"nctId":"NCT04446845","phase":"PHASE4","title":"Double Stimulation Followed by a Fresh Embryo Transfer","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2020-10-30","conditions":"Infertility","enrollment":120},{"nctId":"NCT02810821","phase":"","title":"Gonadal Hormone, Gonadotropin and Cardiovascular Events","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","startDate":"2011-07","conditions":"Aging, Menopause","enrollment":8000},{"nctId":"NCT02430740","phase":"PHASE4","title":"Tailored Ovarian Stimulation Based on BMI, AMH, AFC","status":"UNKNOWN","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2016-01","conditions":"Infertility","enrollment":300},{"nctId":"NCT03197077","phase":"PHASE3","title":"Optimisation of Follicular Recruitment in IVM Cycles","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2017-11-01","conditions":"Infertility, Female, Polycystic Ovary Syndrome","enrollment":145},{"nctId":"NCT05778331","phase":"","title":"The Difference Between POSEIDON Group 3 and Group 4 as Regards IVF","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-01-10","conditions":"Infertility, Female, IVF","enrollment":340},{"nctId":"NCT05571111","phase":"PHASE2","title":"Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation","status":"WITHDRAWN","sponsor":"Ferring Pharmaceuticals","startDate":"2022-10-04","conditions":"Infertility","enrollment":""},{"nctId":"NCT05648136","phase":"NA","title":"Immune Profile Analysis and Biomarker Identification in Women With Repeated Implantation Failure or Unexplained Recurrent Spontaneous Miscarriage","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2022-12-02","conditions":"Repeated Embryo Implantation Failure, Recurrent Miscarriage, Immune System","enrollment":150},{"nctId":"NCT04193930","phase":"NA","title":"Different Protocols in Ovarian Stimulation in Intracytoplasmic Sperm Injection Cycles","status":"WITHDRAWN","sponsor":"Assiut University","startDate":"2021-01-01","conditions":"ART","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Gonal-f"],"phase":"marketed","status":"active","brandName":"Recombinant Follicle Stimulating Hormone","genericName":"Recombinant Follicle Stimulating Hormone","companyName":"Bezmialem Vakif University","companyId":"bezmialem-vakif-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Recombinant FSH binds to follicle-stimulating hormone receptors on granulosa cells to stimulate follicular growth and estrogen production in the ovaries. Used for Infertility in women undergoing assisted reproductive technology (ART), Anovulation and ovulatory disorders in women.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}